Medical diagnostic business
Partner with Experts in Research and Diagnostic Assays Development
Explore More
About Us
Biotechnology is a frontline area of science with immense potential for the benefit of humankind. Borne out of the Cradle of Humankind (Africa), our company is a pioneering biotech firm that was established in South Africa as a research project in 2015.
In 2018, we launched Capebio™ Technologies (Capebio™SA) as a 100% privately owned company.
At Capebio™SA, we mine microbial data from unique African microbial ecosystems in search of genetic material that codes for novel biomolecules (e.g., enzymes, proteins and peptides).
We use OUR PROPRIETARY ARTIFICIAL INTELLIGENCE PLATFORM to discover and develop these molecules with precision, acceleration and sureness before downstream developmental processes.
Our Mission
To develop the “best-in-class” healthcare solutions in Africa, for Africa and the world.
Our Vision
To create excellent innovations that improve the quality of life in Africa and beyond.
Our Values
Integrity, Accountability, Responsible Innovation, Diversity, and Inclusion.
Our company is led by a board of experts in Life Sciences, Corporate Finance, Investments, and International Trade, with alumni from top institutions like Oxford, Cambridge, and the University of Cape Town.
Our R&D team includes scientists with over 15 years of experience in molecular biology, AI, and bioinformatics, while our production scientists are trained in biomanufacturing and quality assurance by the CSIR.
Under the leadership of our founding CEO, we have assembled Africa’s top talent in molecular biology, corporate finance, and business administration.
Our commercialization team consists of scientists skilled in sales and marketing, ensuring exceptional client support.
Additionally, our business administrators play a crucial role in efficient operations and stakeholder engagement.
We take pride in our highly skilled team, committed to innovation, excellence, and client success.
Media & News
Over the last 5 years, we have been making headlines for the right reasons. Our innovative capabilities have not only put us on the global stage but have raised awareness of the scientific talent that South Africa possesses. We have learned a lot from this journey, and we believe we will be able to do even much better going forward. We have demonstrated many times all our core values and were at the heart of Southern Africa’s response to the COVID-19 Pandemic, by rapidly deploying our talent and technology to launch regulatory-approved PCR In Vitro diagnostic (IVD) tests. We strongly believe that we will deliver on our long-term courageous commitment in ensuring that our innovations impact ordinary lives beyond Southern African shores.
